Heartseed

About

Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine”.

Tokyo,Tokyo,Japan
11 - 50

Highlights

Details

Last Funding Type: Series B
Last Funding Money Raised: $26M
Industries: Beauty,Biotechnology,Health Care,Medical,Nursing and Residential Care
Founded date: Jan 1, 2015
Number Of Employee: 11 - 50
Operating Status: Active

Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$63M ¥1B

Heartseed has raised a total of $63M ¥1B in funding over 2 rounds. Their latest funding was raised on Jun 11, 2021 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 11, 2021	Series C	$37M	9	—	—	Detail
Mar 10, 2020	Corporate Round	¥100.34M	2	—	—	Detail
Nov 21, 2019	Series B	$26M	6	—	—	Detail
Jul 30, 2018	Series A	¥800M	3	Angel Bridge	—	Detail
Mar 14, 2016	Seed	¥100M	1	Angel Bridge	—	Detail

Investors

Number of Lead Investors

Number of Investors

2

15

Heartseed is funded by 15 investors. Angel Bridge and ITOCHU Chemical Frontier are the most recent investors.

Investor Name	Lead Investor	Funding Round
Angel Bridge	Yes	Series A
ITOCHU Chemical Frontier	—	Series C
Keio Innovation Initiative	—	Series C
Medical Incubator Japan	—	Series C
Medipal Holdings	—	Series C
Nissay Capital	—	Series C
SBI Group	—	Series C
SMBC Venture Capital	—	Series C
Sumitomo Mitsui Trust Investment	—	Series C
UTokyo Innovation Platform	—	Series C